Fig. 1From: Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 studyStudy design and patient flow chart. a Study design. b Patient flow chart. ITT intention-to-treat, MTX methotrexate, PKS pharmacokinetic set, PPS per-protocol set, R randomized, SS1 safety set 1, SS2 safety set 2Back to article page